
|Articles|May 1, 2017
- Pharmaceutical Executive-05-01-2017
- Volume 37
- Issue 5
Pharmaceutical Executive, May 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive May 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 8 years ago
Brand of the Year: A Retrospectiveover 8 years ago
Portfolio Management Health Checkover 8 years ago
Launch for Long-Term Successover 8 years ago
Merck’s Latest Shot Against Shinglesalmost 9 years ago
Measuring the Value of Prescription Drugsalmost 9 years ago
Life Sciences' Shifting Sands: 5 Trends that Threaten the Status Quoalmost 9 years ago
New Life in European Drug Pricing Spatalmost 9 years ago
Country Report: SwitzerlandNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Releases 2025 Financial Report and 2026 Sales and Operations Profit Outlook
2
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
3
Novartis’ Q4 Recap Shows Signs of Looming Patent Cliff
4
FDA Rejects AstraZeneca’s Application for Subcutaneous Indication of Saphnelo
5



